Siemens Healthineers AG

SHL

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2025

    Employees

    73,000

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,585.8014.400.17%
CAC 407,864.4446.05-0.58%
DAX 4023,999.17123.23-0.51%
Dow JONES (US)41,859.091.35-0.00%
FTSE 1008,739.2647.20-0.54%
HKSE23,636.9192.600.39%
NASDAQ18,925.7353.090.28%
Nikkei 22537,182.81196.940.53%
NZX 50 Index12,596.5065.75-0.52%
S&P 5005,842.012.60-0.04%
S&P/ASX 2008,359.3010.600.13%
SSE Composite Index3,372.098.10-0.24%

Market Movers